| Dr Christopher Matthew Mutter, DO | |
|
22 Bramhall St, Portland, ME 04102-3134 | |
| (207) 828-2100 | |
| Not Available |
| Full Name | Dr Christopher Matthew Mutter |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 10 Years |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104231687 | NPI | - | NPPES |
| 1104231687 | Medicaid | ME |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital, The | North conway, NH | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Penobscot Bay Medical Center | Rockport, ME | Hospital |
| St Mary's Regional Medical Center | Lewiston, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Healthcare Partners Pa | 7618871245 | 265 |
| Spectrum Healthcare Partners Pa | 7618871245 | 265 |
News Archive
Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669488011 PECOS PAC ID: 7618871245 Enrollment ID: O20040423000266 |
News Archive
Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669488011 PECOS PAC ID: 7618871245 Enrollment ID: O20040423000305 |
News Archive
Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417613456 PECOS PAC ID: 7618871245 Enrollment ID: O20211213000919 |
News Archive
Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Matthew Mutter, DO 324 Gannett Dr Ste 200, South Portland, ME 04106-3266 Ph: (207) 448-2780 | Dr Christopher Matthew Mutter, DO 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 828-2100 |
News Archive
Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.
Sen. Edward Kennedy (D-Mass.) on Monday at a forum co-sponsored by the Alliance for Health Reform and the Robert Wood Johnson Foundation said that Congress likely will have the ability to authorize the $50 billion over five years needed to enroll all children eligible for SCHIP but "hedged on whether it would do so this year or over the next several years," CQ HealthBeat reports.
› Verified 7 days ago
Sean Henry Novak, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 857-228-5816 | |
Michael O'malley Quinn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Elena Leah Resnick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Matthew D Ralston, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Jerald Christopher Kuhn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Whitney Beeler, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4735 Fax: 207-662-6388 | |
David Russell Langdon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 |